Effect of H. pylori Infection on L-DOPA Pharmacokinetics in Patients with Parkinson's disease

被引：0
|
作者：
Oda, S.
Saitoh, Y.
Takei, J.
Watanabe, S.
Mukai, Y.
Takahashi, Y.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
519
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [41] Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients
    Pierantozzi, M
    Pietroiusti, A
    Sancesario, G
    Lunardi, G
    Fedele, E
    Giacomini, P
    Frasca, S
    Galante, A
    Marciani, MG
    Stanzione, P
    NEUROLOGICAL SCIENCES, 2001, 22 (01) : 89 - 91
  • [42] Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients
    M. Pierantozzi
    A. Pietroiusti
    G. Sancesario
    G. Lunardi
    E. Fedele
    P. Giacomini
    S. Frasca
    A. Galante
    M. G. Marciani
    P. Stanzione
    Neurological Sciences, 2001, 22 : 89 - 91
  • [43] Molecular Effects of L-dopa Therapy in Parkinson's Disease
    Dorszewska, Jolanta
    Prendecki, Michal
    Lianeri, Margarita
    Kozubski, Wojciech
    CURRENT GENOMICS, 2014, 15 (01) : 11 - 17
  • [44] The evolution of the acute response to L-dopa in Parkinson's disease
    Hughes, AJ
    Lees, AJ
    MOVEMENT DISORDERS, 2002, 17 : S97 - S98
  • [45] L-Dopa plasma levels variability in Parkinson's disease
    Albani, G.
    Cattaldo, S.
    Mauro, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S118
  • [46] Pharmacokinetics and pharmacodynamics of L-DOPA after acute and 6-week tolcapone administration in patients with Parkinson's disease
    Napolitano, A
    Del Dotto, P
    Petrozzi, L
    Dell'Agnello, G
    Bellini, G
    Gambaccini, G
    Bonuccelli, U
    CLINICAL NEUROPHARMACOLOGY, 1999, 22 (01) : 24 - 29
  • [47] L-DOPA and cortical associative plasticity in Parkinson's disease
    Suppa, Antonio
    Bologna, Matteo
    Berardelli, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (04) : 638 - 639
  • [48] THE L-DOPA RESPONSE IN PATHOLOGICALLY CONFIRMED PARKINSON'S DISEASE
    Pitz, Vanessa
    Malek, Naveed
    Grosset, Katherine A.
    Grosset, Donald G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [49] Paradoxical response to L-dopa and apomorphine in the Parkinson's disease
    García-Soldevilla, MA
    Puertas, I
    Barcenilla, B
    Sayed, Y
    García-Albea, E
    Jiménez-Jiménez, FJ
    MOVEMENT DISORDERS, 2002, 17 : S96 - S96
  • [50] Parkinson's disease, L-DOPA, and endogenous morphine: A revisit
    Stefano, George B.
    Mantione, Kirk J.
    Kralickova, Milena
    Ptacek, Radek
    Kuzelova, Hana
    Esch, Tobias
    Kream, Richard M.
    MEDICAL SCIENCE MONITOR, 2012, 18 (08): : RA133 - RA137
12345